SIGA Technologies Inc
Closed
SectorHealthcare
3.47 1.46
Overview
Share price change
24h
Min
3.39
Max
3.48
Income | -34M -3.5M |
|---|---|
Sales | 2.4M 6.2M |
P/E Sector Avg | 12.821 60.149 |
EPS | -0.048 |
Profit margin | -55.334 |
Employees | 49 |
EBITDA | 5.6M -3.9M |
Next Earnings | 4 Aug 2026 |
|---|
Market Cap | -75M 257M |
|---|---|
Previous open | 2.01 |
Previous close | 3.47 |
News Sentiment
By Acuity
50%
50%
156 / 340 Healthcare
SIGA Technologies Inc Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
SIGA Technologies Inc Forecast
Sentiment
By Acuity
156 / 340 Healthcare
News Sentiment
Neutral
Volatility
Below average
News Volume (RCV)
Above average
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$
About SIGA Technologies Inc
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security related markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was incorporated in 1995 and is headquartered in New York, New York.
